Neutralizing human anti-IGFR antibody
The present invention includes fully human, neutralizing, monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1). The antibodies are useful for treating or preventing cancer in a subject. Also included are methods of using and producing the antibodies of the invention.
Schering Corporation
A C A A A C C A C C C A C A A C
A61P C07K A61P A61P A61P C07K C07K A61P C07K C07K C07K A61P C07K A61K A61P C07K
inventional additional inventional inventional inventional additional additional inventional additional inventional additional inventional additional additional inventional inventional
Denise Diane Judith Jonathan A. Leonard Peter Robert Yan Mohan
Williams Feingersh Hailey Pachter Presta Brams Greenberg Wang Srinivasan